Tenaya Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $35.7M | $314.2M | $38.1M |
| FY2022 | $35.6M | $278.9M | $95.3M |
| FY2023 | $31.1M | $170.5M | $45.7M |
| FY2024 | $27.1M | $119.9M | $4.3M |
| FY2025 | $23.7M | $146.9M | $100.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $35.7M | $314.2M | $38.1M |
| FY2022 | $35.6M | $278.9M | $95.3M |
| FY2023 | $31.1M | $170.5M | $45.7M |
| FY2024 | $27.1M | $119.9M | $4.3M |
| FY2025 | $23.7M | $146.9M | $100.5M |